GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Implantica AG (OSTO:IMP A SDB) » Definitions » EV-to-EBIT

Implantica AG (OSTO:IMP A SDB) EV-to-EBIT : (As of Jun. 28, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Implantica AG EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Implantica AG's Enterprise Value is kr0.00 Mil. Implantica AG does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Implantica AG's EV-to-EBIT at this moment.

The historical rank and industry rank for Implantica AG's EV-to-EBIT or its related term are showing as below:

OSTO:IMP A SDB's EV-to-EBIT is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 19.375
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Implantica AG's Enterprise Value for the quarter that ended in . 20 was kr0.00 Mil. Implantica AG does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Implantica AG's Earnings Yield (Joel Greenblatt) % at this moment.

Implantica AG EV-to-EBIT Historical Data

The historical data trend for Implantica AG's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Implantica AG EV-to-EBIT Chart

Implantica AG Annual Data
Trend
EV-to-EBIT

Implantica AG Semi-Annual Data
EV-to-EBIT

Competitive Comparison of Implantica AG's EV-to-EBIT

For the Medical Devices subindustry, Implantica AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Implantica AG's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Implantica AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Implantica AG's EV-to-EBIT falls into.


;
;

Implantica AG EV-to-EBIT Calculation

Implantica AG's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.000/
=

Implantica AG  (OSTO:IMP A SDB) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Implantica AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in . 20 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: . 20 ) =EBIT / Enterprise Value (Q: . 20 )
=/
= %

Implantica AG EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Implantica AG's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Implantica AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Implantica AG (OSTO:IMP A SDB) » Definitions » EV-to-EBIT
Comparable Companies
Traded in Other Exchanges
8IM1:Germany
Address
Aeulestrasse 45, Vaduz, LIE, 9490
Website
https://www.implantica.com
Implantica AG is a medtech group providing effective care for serious health conditions and improving patients' quality of life by bringing advanced technology into the body. The therapies Implantica develops are based on implants that are medical devices inserted into the patient's body and are intended to remain in place permanently or semi-permanently, using electrical power provided by a battery. The company has developed a broad, patent-protected, product pipeline based partly on its two platform technologies. Its lead product, RefluxStop, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results.

Implantica AG Headlines

No Headlines